LifeMD, Inc.
LFMD
$6.09
$0.030.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 212.45M | 193.06M | 178.28M | 163.56M | 152.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 212.45M | 193.06M | 178.28M | 163.56M | 152.55M |
| Cost of Revenue | 24.07M | 19.99M | 19.76M | 19.29M | 18.90M |
| Gross Profit | 188.39M | 173.06M | 158.52M | 144.28M | 133.65M |
| SG&A Expenses | 187.10M | 176.29M | 163.15M | 149.09M | 136.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.92M | 7.01M | 6.60M | 6.03M | 5.44M |
| Total Operating Expenses | 228.60M | 212.39M | 197.50M | 181.37M | 167.04M |
| Operating Income | -16.14M | -19.33M | -19.22M | -17.81M | -14.49M |
| Income Before Tax | -18.33M | -21.52M | -21.56M | -20.62M | -17.41M |
| Income Tax Expenses | 402.00K | 660.50K | 428.00K | 428.00K | 428.00K |
| Earnings from Continuing Operations | -18.73 | -22.19 | -21.99 | -21.05 | -17.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -153.20K | -322.10K | -1.51M | -2.31M | -2.76M |
| Net Income | -18.88M | -22.51M | -23.50M | -23.36M | -20.60M |
| EBIT | -16.14M | -19.33M | -19.22M | -17.81M | -14.49M |
| EBITDA | -14.67M | -17.97M | -17.96M | -16.60M | -13.31M |
| EPS Basic | -0.54 | -0.64 | -0.70 | -0.75 | -0.70 |
| Normalized Basic EPS | -0.29 | -0.34 | -0.39 | -0.43 | -0.40 |
| EPS Diluted | -0.54 | -0.65 | -0.71 | -0.75 | -0.71 |
| Normalized Diluted EPS | -0.29 | -0.34 | -0.39 | -0.43 | -0.40 |
| Average Basic Shares Outstanding | 164.77M | 159.30M | 151.75M | 143.02M | 135.46M |
| Average Diluted Shares Outstanding | 164.77M | 159.30M | 151.75M | 143.02M | 135.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -16.45% | -13.80% | -13.22% | -13.30% | -15.08% |